ANOVA a test of the linear regression model. by Dania AL-Najjar (11840857)

Subjects:

Linear regression between PCDD/F TEQ and ∑PCDD/F in different study areas. by Matti Viluksela (321291)

Linear regression between PCB TEQ and PCDD/F TEQ in different study areas. by Matti Viluksela (321291)

Summary statistics from linear models with biomarkers. by Margaret Sunitha Selvaraj (13994016)

Summary statistics from linear models with metabolites. by Margaret Sunitha Selvaraj (13994016)

Trends in the incidence of multidrug-resistant <i>Pseudomonas aeruginosa</i> (MRPA) per 1000 patients, by month, during Phase 2 of the intervention period. by Naoya Itoh (6029276)

“…The level of the monthly incidence of MRPA did not decrease (coefficient: 0.09; 95% confidence interval [CI]: −0.015 to 0.19, <i>p</i> = 0.10), although the trend of the infection was significantly reduced (coefficient: −0.02; 95% CI: −0.02 to −0.004, <i>p</i> = 0.02).…”

Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during Phase 2 of the intervention period. by Naoya Itoh (6029276)

“…The level of the monthly incidence of MRSA did not decrease (coefficient: 0.12; 95% confidence interval [CI]: −0.16 to 0.42, p = 0.40), although there was a significant reduction in the trend of the infection (coefficient: −0.05; 95% CI: −0.09 to −0.013, p = 0.01).…”

Trends in the days of antipseudomonal agent (piperacillin–tazobactam, cefepime, and cefozopran) therapy per 100 patients, by month, during Phase 2 of the intervention period. by Naoya Itoh (6029276)

Multiple linear regression analysis results. by Muxi Chen (9294270)

Subjects:

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

Patients with high baseline gut richness and diversity have significantly greater decreases in diversity over time. by Molly B. El Alam (10231830)

Coefficients of the reduced linear regression model without multicollinearity. by Dania AL-Najjar (11840857)

Subjects:

Flowchart of neural network and linear regression prediction model. by Dania AL-Najjar (11840857)

Subjects:

Coefficients of the reduced linear regression model without multicollinearity. by Dania AL-Najjar (11840857)

Subjects:

Trends in the days of narrow-spectrum antibiotic (ampicillin, ampicillin–sulbactam, cefazolin, and cefmetazole) therapy per 100 patients, by month, during Phase 2 of the interventi... by Naoya Itoh (6029276)

The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER. by Charlotte J. van Ginkel (20790466)

“…PS decreased TEER. (C) Different treatments (treatment groups n = 8)with HA and/or CS did not affect TEER recovery after PS treatment, full recovery was seen in all groups after 24 hours. …”

Estimated marginal means of the RMS per muscle, based on the linear mixed-effects model. by I. Moll (14227650)

Estimated marginal means of the MF per muscle, based on the linear mixed-effects model. by I. Moll (14227650)

Linear trends of weekly prescription rates of NVBP varieties. by Chenxuan Zhu (22622476)

Estimation of the coefficients of a generalised linear model of posttraumatic stress symptomatology. by Beatriz Arregui-Gallego (21553735)

Subjects: